| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 5.44▲ | 5.38▲ | 5.37▲ | 5.17▲ | 5.33▲ |
| MA10 | 5.37▲ | 5.35▲ | 5.28▲ | 4.96▲ | 5.81▼ |
| MA20 | 5.31▲ | 5.12▲ | 5.05▲ | 5.22▲ | 6.01▼ |
| MA50 | 4.99▲ | 5.15▲ | 5.33▲ | 5.88▼ | 5.78▼ |
| MA100 | 5.34▲ | 5.67▼ | 5.85▼ | 6.08▼ | 5.12▲ |
| MA200 | 5.85▼ | 6.08▼ | 6.11▼ | 5.87▼ | 5.88▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.014▲ | 0.064▲ | 0.092▲ | 0.098▲ | -0.161▼ |
| RSI | 70.388▲ | 65.117▲ | 62.548▲ | 55.647▲ | 47.794▼ |
| STOCH | 70.337 | 78.374 | 85.732▲ | 61.883 | 24.541 |
| WILL %R | 0.000▲ | 0.000▲ | 0.000▲ | 0.000▲ | -54.839 |
| CCI | 206.279▲ | 116.191▲ | 123.024▲ | 208.828▲ | -94.643 |
|
Thursday, December 04, 2025 10:04 AM
ICCC's innovative, antibiotic-free cattle health products drive margin recovery, real-world adoption and stock gains.
|
|
Monday, November 24, 2025 05:02 PM
ImmuCell Corp (ICCC) reports a significant turnaround in net income and gross margins, while addressing sales challenges and preparing for future growth.
|
|
Thursday, November 20, 2025 08:18 AM
Shares of ImmuCell Corporation ICCC have fallen sharply since the release of third-quarter 2025 earnings. The stock has declined 22.7% since the announcement compared with a 3.9% drop of the S&P 500 ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 05/12/25 | 5.30 | 5.64 | 5.21 | 5.64 | 20,744 |
| 04/12/25 | 5.33 | 5.5512 | 5.10 | 5.21 | 47,233 |
| 03/12/25 | 4.72 | 5.40 | 4.72 | 5.25 | 8,447 |
| 02/12/25 | 4.81 | 5.00 | 4.74 | 5.00 | 9,960 |
| 01/12/25 | 4.91 | 4.91 | 4.70 | 4.74 | 11,756 |
| 28/11/25 | 4.89 | 5.00 | 4.83 | 4.84 | 7,242 |
| 26/11/25 | 4.75 | 5.36 | 4.72 | 4.80 | 24,448 |
| 25/11/25 | 4.70 | 4.83 | 4.68 | 4.68 | 13,146 |
| 24/11/25 | 4.67 | 4.8085 | 4.67 | 4.72 | 10,076 |
| 21/11/25 | 4.56 | 4.68 | 4.52 | 4.68 | 8,583 |
|
|
||||
|
|
||||
|
|